Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

Kercheville Advisors LLC Has $549,000 Holdings in Bristol-Myers Squibb (NYSE:BMY)

Grimes & Company Inc. Reduces Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Dynamic Advisor Solutions LLC Raises Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers Squibb Presents Promising Blood Cancer Drug Data at EHA Congress

10 Best Stocks to Buy For Beginners Now

QRG Capital Management Inc. Purchases 43,977 Shares of Bristol-Myers Squibb (NYSE:BMY)

Good Life Advisors LLC Buys 10,404 Shares of Bristol-Myers Squibb (NYSE:BMY)

Q1 EPS Estimate for Bristol-Myers Squibb Boosted by Analyst

Mn Services Vermogensbeheer B.V. Sells 58,400 Shares of Bristol-Myers Squibb (NYSE:BMY)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Lowers Holdings in Bristol-Myers Squibb (NYSE:BMY)

7,137 Shares in Bristol-Myers Squibb (NYSE:BMY) Bought by McBroom & Associates LLC

Bristol-Myers Squibb (BMY) Announces Positive Data From the Pivotal Phase 3 POETYK PsA-1 Trial

Jim Cramer on Bristol Myers: "We Need to See That Stock Back Up at $60" - Insider Monkey

Avaii Wealth Management LLC Acquires 67,221 Shares of Bristol-Myers Squibb (NYSE:BMY)

NorthCrest Asset Manangement LLC Cuts Stake in Bristol-Myers Squibb (NYSE:BMY)

Zhang Financial LLC Has $390,000 Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Rockland Trust Co. Reduces Stake in Bristol-Myers Squibb (NYSE:BMY)

Secondary analysis of the EMPACT-MI trial reveals cardiovascular-kidney efficacy and safety of empagliflozin after acute myocardial infarction

Education of healthcare professionals to improve guideline adherence in atrial fibrillation: the STEEER-AF cluster-randomized clinical trial

Keeping the immuno-oncology flame burning

Fort Washington Investment Advisors Inc. OH Buys 18,876 Shares of Bristol-Myers Squibb (NYSE:BMY)

Davis Investment Partners LLC Boosts Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

BioNTech to acquire CureVac in $1.25 billion all-stock deal

Wedge Capital Management L L P NC Sells 511,384 Shares of Bristol-Myers Squibb (NYSE:BMY)

In the clinic for June 12, 2025 | BioWorld

Curbstone Financial Management Corp Boosts Stake in Bristol-Myers Squibb (NYSE:BMY)

Franklin Street Advisors Inc. NC Buys 8,191 Shares of Bristol-Myers Squibb (NYSE:BMY)

CX Institutional Sells 8,445 Shares of Bristol-Myers Squibb (NYSE:BMY)

Farther Finance Advisors LLC Acquires 13,372 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb To Present At Goldman Sachs Global Conference; Webcast At 10:00 AM ET

Philochem, BMS ink $1.35B deal for prostate cancer candidate OncoACp3 | BioWorld

TERN-501 monotherapy and combination therapy with TERN-101 in metabolic dysfunction-associated steatohepatitis: the randomized phase 2a DUET trial

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties | Morningstar

Handelsbanken Fonder AB Purchases 6,956 Shares of Bristol-Myers Squibb (NYSE:BMY)

224,806 Shares in Bristol-Myers Squibb (NYSE:BMY) Bought by Nepsis Inc.

Abacus FCF Advisors LLC Grows Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Park Avenue Securities LLC Acquires 9,973 Shares of Bristol-Myers Squibb (NYSE:BMY)

CHICAGO TRUST Co NA Acquires 7,890 Shares of Bristol-Myers Squibb (NYSE:BMY)

Toth Financial Advisory Corp Grows Holdings in Bristol-Myers Squibb (NYSE:BMY)

Greystone Financial Group LLC Makes New $9.76 Million Investment in Bristol-Myers Squibb (NYSE:BMY)

Vest Financial LLC Increases Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Capital Investment Advisors LLC Has $14.01 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by UMB Bank n.a.

Bristol-Myers Squibb (NYSE:BMY) Stock Holdings Cut by Bourne Lent Asset Management Inc.

Procyon Advisors LLC Purchases 9,763 Shares of Bristol-Myers Squibb (NYSE:BMY)

Hennion & Walsh Asset Management Inc. Has $1.06 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Receives Consensus Recommendation of "Hold" from Brokerages

Wall Street Zen Downgrades Bristol-Myers Squibb (NYSE:BMY) to Buy
Was Jim Cramer Right About Bristol-Myers Squibb Co. (BMY)?

Denovo Biopharma Announces Formation of Neuroscience Scientific Advisory Board to Advance Precision Medicine in Depression | Morningstar

Generali Investments Management Co LLC Increases Stake in Bristol-Myers Squibb (NYSE:BMY)

Genetic mutation identified as key factor in immunotherapy resistance for melanoma

RFG Advisory LLC Buys 11,208 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Merit Financial Group LLC

NBC Securities Inc. Has $623,000 Holdings in Bristol-Myers Squibb (NYSE:BMY)

Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma

TruWealth Advisors LLC Buys New Stake in Bristol-Myers Squibb (NYSE:BMY)

Contravisory Investment Management Inc. Acquires 127,239 Shares of Bristol-Myers Squibb (NYSE:BMY)

Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial

Undetectable Disease Status in Myeloma Similar With Drug Therapy, Transplantation

Truist Lifts BioNTech (BNTX) Price Target After New Partnership
Bristol-Myers Squibb (NYSE:BMY) Collaborates With BioNTech For Antibody Development In Cancer Treatment

Bristol-Myers Squibb (NYSE:BMY) Stake Raised by Viking Fund Management LLC

Fulton Bank N.A. Reduces Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by LVW Advisors LLC

Why BioNTech SE (BNTX) Skyrocketed On Monday

Bristol-Myers Squibb Company and BioNTech SE Partner to Advance Next-Gen Cancer Therapies

Adding Neoadjuvant Nivolumab to Chemo Improved Survival in Resectable NSCLC

Bristol Myers' cancer deal is promising, but doesn't change our stance on stock yet

Bristol-Myers (BMY) Licenses BioNTech's Immunotherapy in $11 billion Deal

Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race | Morningstar

Douglas Lane & Associates LLC Sells 48,110 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Milestone Asset Management LLC

Bristol Myers to help develop cancer drug in BioNTech partnership
Bristol Myers to Pay $1.5B for BioNTech Cancer Drug Deal | Newsmax.com

BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types | The Manila Times

BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types | Morningstar

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Rhumbline Advisers

GAMMA Investing LLC Acquires 2,386,970 Shares of Bristol-Myers Squibb (NYSE:BMY)

This Week in Chancery Court: Squarespace, Bristol-Myers Squibb

BioNTech, Bristol Myers Ink Strategic Partnership To Co-Develop BNT327 For Several Solid Tumor Type

Biontech trades half of bispecific BNT-327 to BMS for potential $11B+ | BioWorld

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and Bristol-Myers Squibb (BMY) | Markets Insider

Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic dissemination

Immunotherapy Drugs Show Major Progress in Early-Stage Cancer

Meyer Handelman Co. Sells 7,905 Shares of Bristol-Myers Squibb (NYSE:BMY)

Wealth Enhancement Advisory Services LLC Purchases 120,192 Shares of Bristol-Myers Squibb (NYSE:BMY)

Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase II NeoCOAST-2 trial

Bristol-Myers Squibb (NYSE:BMY) Stock Price Up 1% - Here's What Happened

Webster Bank N. A. Cuts Stake in Bristol-Myers Squibb (NYSE:BMY)

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial

Why the stock rally fizzled - plus, our latest thinking on Goldman and Bristol Myers

C3.ai, Inc. (NYSE:AI) Q4 2025 Earnings Call Transcript

Fairtree Asset Management Pty Ltd Invests $550,000 in Bristol-Myers Squibb (NYSE:BMY)

Chancellor Financial Group WB LP Purchases Shares of 8,673 Bristol-Myers Squibb (NYSE:BMY)

111 Capital Purchases New Holdings in Bristol-Myers Squibb (NYSE:BMY)
BristolMyers News
Latest news
Show more
World Stock Indexes today: Sensex, Nifty, Dow, S&P 500, Nasdaq, Nikkei

Morning Note: BOJ Holds; US-UK Trade Deal; Oil Rises on Mideast Tension

Morning Note: Geopolitical Risks Persist; Major Central Bank & Economic Data Week Ahead